<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=1620119" created="14/11/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>1620119</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="Oct2_transactivation" sem="Other"><term id="T2" lex="Oct2" sem="Protein_molecule">Oct2</term> transactivation</term> from a <term id="T3" lex="remote_enhancer_position" sem="DNA_domain_or_region">remote enhancer position</term> requires a <term id="T4" lex="B-cell-restricted_activity" sem="Other">B-cell-restricted activity</term>.</sentence>
<event id="E1">
<type class="Positive_regulation"/>
<theme idref="E2"/>
<cause idref="T2"/>
<clue>Oct2 <clueType>transactivation</clueType> from a remote enhancer position requires a B-cell-restricted activity.</clue>
</event>
<event id="E2">
<type class="Transcription"/>
<theme idref="T3"/>
<clue>Oct2 <clueType>transactivation</clueType> <linkTheme>from</linkTheme> a remote enhancer position requires a B-cell-restricted activity.</clue>
<comment>CAUTION: transactivation &quot;from&quot;</comment></event>
<event id="E3">
<type class="Positive_regulation"/>
<theme idref="E1"/>
<cause idref="T4"/>
<clue>Oct2 transactivation from a remote enhancer position <clueType>requires</clueType> a <clueLoc>B-cell</clueLoc>-restricted activity.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">Previous cotransfection experiments had demonstrated that ectopic expression of the <term id="T5" lex="lymphocyte-specific_transcription_factor" sem="Protein_family_or_group">lymphocyte-specific transcription factor</term> <term id="T6" lex="Oct2" sem="Protein_molecule">Oct2</term> could efficiently activate a <term id="A1" sem="DNA_domain_or_region"><term id="T7" lex="promoter" sem="DNA_domain_or_region">promoter</term> containing an <term id="T8" lex="octamer_motif" sem="DNA_substructure">octamer motif</term></term>.</sentence>
<event KT="Other" id="E4">
<type class="Gene_expression"/>
<theme idref="T6"/>
<clue>Previous cotransfection experiments had demonstrated that <clueExperiment>ectopic</clueExperiment> <clueType>expression</clueType> <linkTheme>of</linkTheme> the <clueLoc>lymphocyte</clueLoc>-specific transcription factor Oct2 could efficiently activate a promoter containing an octamer motif.</clue>
</event>
<event KT="Analysis" Source="Other" id="E5">
<type class="Positive_regulation"/>
<theme idref="A1"/>
<cause idref="E4"/>
<clue><clueSource>Previous</clueSource> <clueExperiment>cotransfection experiments</clueExperiment> had <clueKT>demonstrated</clueKT> that ectopic expression of the lymphocyte-specific transcription factor Oct2 could efficiently <clueType>activate</clueType> a promoter containing an octamer motif.</clue>
<comment>TPS: A1</comment></event>
<sentence id="S3"><term id="T9" lex="Oct2" sem="Protein_molecule">Oct2</term> expression was unable to stimulate a <term id="T10" lex="multimerized_octamer_enhancer_element" sem="DNA_domain_or_region">multimerized octamer enhancer element</term> in <term id="T11" lex="HeLa_cell" sem="Cell_cultured">HeLa cells</term>, however.</sentence>
<event KT="Other" id="E6">
<type class="Gene_expression"/>
<theme idref="T9"/>
<clue>Oct2 <clueType>expression</clueType> was unable to stimulate a multimerized octamer enhancer element in HeLa cells, however.</clue>
</event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E7">
<type class="Positive_regulation"/>
<theme idref="T10"/>
<cause idref="E6"/>
<clue>Oct2 expression was <cluePolarity>un</cluePolarity><clueKT><clueCL>able</clueCL></clueKT> to <clueType>stimulate</clueType> a multimerized octamer enhancer element <clueLoc>in HeLa cells</clueLoc>, however.</clue>
</event>
<sentence id="S4">We have tested a variety of <term id="T12" lex="Oct2_isoform" sem="Protein_molecule">Oct2 isoforms</term> generated by <term id="A6" sem="Other">alternative splicing</term> for the capability to activate an <term id="T13" lex="octamer_enhancer" sem="DNA_domain_or_region">octamer enhancer</term> in <term id="T14" lex="nonlymphoid_cell" sem="Cell_natural">nonlymphoid cells</term> and a <term id="T15" lex="B-cell_line" sem="Cell_cultured">B-cell line</term>.</sentence>
<event KT="Investigation" id="E8" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="T13"/>
<cause idref="T12"/>
<clue>We have <clueKT>tested</clueKT> a variety of Oct2 isoforms generated by alternative splicing for the capability to <clueType>activate</clueType> an octamer enhancer <clueLoc>in nonlymphoid cells</clueLoc> and a B-cell line.</clue>
</event>
<event KT="Investigation" id="E24" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="T13"/>
<cause idref="T12"/>
<clue>We have <clueKT>tested</clueKT> a variety of Oct2 isoforms generated by alternative splicing for the capability to <clueType>activate</clueType> an octamer enhancer <clueLoc>in</clueLoc> nonlymphoid cells and a <clueLoc>B-cell line</clueLoc>.</clue>
</event>
<event KT="Other" id="E25">
<type class="Positive_regulation"/>
<theme idref="T12"/>
<cause idref="A6"/>
<clue>We have tested a variety of Oct2 isoforms <clueType>generated</clueType> <linkCause>by</linkCause> alternative splicing for the capability to activate an octamer enhancer in nonlymphoid cells and a B-cell line.</clue>
</event>
<sentence id="S5">Our analyses show that several <term id="T16" lex="Oct2_isoform" sem="Protein_molecule">Oct2 isoforms</term> can stimulate from a remote position but that this stimulation is restricted to <term id="T17" lex="B_cell" sem="Cell_natural">B cells</term>.</sentence>
<event CL="L2" KT="Analysis" id="E9">
<type class="Positive_regulation"/>
<theme idref="T13"/>
<cause idref="T16"/>
<clue>Our analyses <clueKT>show</clueKT> that several Oct2 isoforms <clueCL>can</clueCL> <clueType>stimulate</clueType> from a remote position but that this stimulation is restricted to B cells.</clue>
<comment>NO COREFTHEME</comment></event>
<event KT="Analysis" id="E10">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<clue>Our analyses <clueKT>show</clueKT> that several Oct2 isoforms can stimulate from a remote position but that <corefTheme>this stimulation</corefTheme> is <clueType>restricted</clueType> <clueLoc>to B cells</clueLoc>.</clue>
</event>
<sentence id="S6">This result indicates the involvement of either a <term id="T18" lex="B-cell-specific_cofactor" sem="Protein_family_or_group">B-cell-specific cofactor</term> or a specific modification of a <term id="T19" lex="cofactor" sem="Protein_family_or_group">cofactor</term> or the <term id="T20" lex="Oct2_protein" sem="Protein_molecule">Oct2 protein</term> in <term id="T21" lex="Oct2-mediated_enhancer_activation" sem="Other"><term id="T22" lex="Oct2" sem="Protein_molecule">Oct2</term>-mediated <term id="A2" sem="DNA_domain_or_region">enhancer</term> activation</term>.</sentence>
<event CL="L2" KT="Analysis" id="E11">
<type class="Regulation"/>
<theme idref="E14"/>
<cause idref="T18"/>
<clue>This result <clueKT><clueCL>indicates</clueCL></clueKT> the <clueType>involvement</clueType> <linkCause>of</linkCause> either a B-cell-specific cofactor or a specific modification of a cofactor or the Oct2 protein <linkTheme>in</linkTheme> Oct2-mediated enhancer activation.</clue>
</event>
<event CL="L2" KT="Analysis" id="E12">
<type class="Regulation"/>
<theme idref="E14"/>
<cause idref="E15"/>
<clue>This result <clueKT><clueCL>indicates</clueCL></clueKT> the <clueType>involvement</clueType> <linkCause>of</linkCause> either a B-cell-specific cofactor or a specific modification of a cofactor or the Oct2 protein <linkTheme>in</linkTheme> Oct2-mediated enhancer activation.</clue>
</event>
<event CL="L2" KT="Analysis" id="E13">
<type class="Regulation"/>
<theme idref="E14"/>
<cause idref="E22"/>
<clue>This result <clueKT><clueCL>indicates</clueCL></clueKT> the <clueType>involvement</clueType> <linkCause>of</linkCause> either a B-cell-specific cofactor or a specific modification of a cofactor or the Oct2 protein <linkTheme>in</linkTheme> Oct2-mediated enhancer activation.</clue>
</event>
<event KT="Other" id="E14">
<type class="Positive_regulation"/>
<theme idref="A2"/>
<cause idref="T22"/>
<clue>This result indicates the involvement of either a B-cell-specific cofactor or a specific modification of a cofactor or the Oct2 protein in Oct2<linkCause>-mediated</linkCause> enhancer <clueType>activation</clueType>.</clue>
</event>
<event KT="Other" id="E15">
<type class="Protein_modification"/>
<theme idref="T19"/>
<clue>This result indicates the involvement of either a B-cell-specific cofactor or a specific <clueType>modification</clueType> <linkTheme>of</linkTheme> a cofactor or the Oct2 protein in Oct2-mediated enhancer activation.</clue>
</event>
<event KT="Other" id="E22">
<type class="Protein_modification"/>
<theme idref="T20"/>
<clue>This result indicates the involvement of either a B-cell-specific cofactor or a specific <clueType>modification</clueType> <linkTheme>of</linkTheme> a cofactor or the Oct2 protein in Oct2-mediated enhancer activation.</clue>
</event>
<sentence id="S7">Mutational analyses indicate that the <term id="A4" sem="Protein_domain_or_region"><term id="T23" lex="carboxy-terminal_domain" sem="Protein_domain_or_region">carboxy-terminal domain</term> of <term id="T24" lex="Oct2" sem="Protein_molecule">Oct2</term></term> is critical for <term id="T25" lex="enhancer_activation" sem="Other"><term id="A3" sem="DNA_domain_or_region">enhancer</term> activation</term>.</sentence>
<event CL="L2" KT="Analysis" id="E16">
<type class="Positive_regulation"/>
<theme idref="E17"/>
<cause idref="A4"/>
<clue><clueExperiment>Mutational analyses</clueExperiment> <clueKT><clueCL>indicate</clueCL></clueKT> that the carboxy-terminal domain of Oct2 is <clueType>critical</clueType> <linkTheme>for</linkTheme> enhancer activation.</clue>
<comment>TPS: A4</comment></event>
<event KT="Other" id="E17">
<type class="Positive_regulation"/>
<theme idref="A3"/>
<clue>Mutational analyses indicate that the carboxy-terminal domain of Oct2 is critical for enhancer <clueType>activation</clueType>.</clue>
</event>
<sentence id="S8">Moreover, this domain conferred <term id="T26" lex="enhancing_activity" sem="Other">enhancing activity</term> when fused to the <term id="T27" lex="Oct1_protein" sem="Protein_molecule">Oct1 protein</term>, which by itself was unable to stimulate from a remote position.</sentence>
<event KT="Method" id="E18">
<type class="Mutagenesis"/>
<theme idref="A4"/>
<theme idref="T27"/>
<clue>Moreover, <corefTheme>this domain</corefTheme> conferred enhancing activity when <clueType>fused</clueType> <linkTheme>to</linkTheme> the Oct1 protein, which by itself was unable to stimulate from a remote position.</clue>
<comment>TPS: A4; ARTIFICIAL</comment></event>
<event id="E19">
<type class="Positive_regulation"/>
<theme idref="T26"/>
<cause idref="E18"/>
<clue>Moreover, <corefCause>this domain</corefCause> <clueType>conferred</clueType> enhancing activity <linkCause>when</linkCause> fused to the Oct1 protein, which by itself was unable to stimulate from a remote position.</clue>
<comment>TPS: A4</comment></event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E20">
<type class="Positive_regulation"/>
<theme idref="T26"/>
<cause idref="T27"/>
<clue>Moreover, this domain conferred enhancing activity when fused to the Oct1 protein, which <corefCause>by itself</corefCause> was <cluePolarity>un</cluePolarity><clueKT><clueCL>able</clueCL></clueKT> to <clueType>stimulate</clueType> from a remote position.</clue>
<comment>NO COREFTHEME</comment></event>
<sentence id="S9">The <term id="A5" sem="Protein_domain_or_region"><term id="T28" lex="glutamine-rich_activation_domain" sem="Protein_domain_or_region">glutamine-rich activation domain</term> present in the <term id="T29" lex="amino-terminal_portion_of_Oct2" sem="Protein_domain_or_region">amino-terminal portion of <term id="T30" lex="Oct2" sem="Protein_molecule">Oct2</term></term></term> and the <term id="T31" lex="POU_domain" sem="Protein_domain_or_region">POU domain</term> contribute only marginally to the <term id="T32" lex="transactivation_function" sem="Other">transactivation function</term> from a distal position.</sentence>
<event id="E21">
<type class="Positive_regulation"/>
<theme idref="T32"/>
<cause idref="A5"/>
<clue>The glutamine-rich activation domain present in the amino-terminal portion of Oct2 and the POU domain <clueType>contribute</clueType> only marginally <linkTheme>to</linkTheme> the transactivation function from a distal position.</clue>
<comment>TPS: A5; CAUTION, though only marginally</comment></event>
<event id="E23">
<type class="Positive_regulation"/>
<theme idref="T32"/>
<cause idref="T31"/>
<clue>The glutamine-rich activation domain present in the amino-terminal portion of Oct2 and the POU domain <clueType>contribute</clueType> only marginally <linkTheme>to</linkTheme> the transactivation function from a distal position.</clue>
<comment>CAUTION, though only marginally</comment></event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
